Literature DB >> 28705434

Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting.

Rahul Rattan1, Somnath Bhattacharjee2, Hong Zong2, Corban Swain1, Muneeb A Siddiqui1, Scott H Visovatti3, Yogendra Kanthi4, Sajani Desai1, David J Pinsky3, Sascha N Goonewardena5.   

Abstract

The surface properties of nanoparticles (NPs) are a major factor that influences how these nanomaterials interact with biological systems. Interactions between NPs and macrophages of the reticuloendothelial system (RES) can reduce the efficacy of NP diagnostics and therapeutics. Traditionally, to limit NP clearance by the RES system, the NP surface is neutralized with molecules like poly(ethylene glycol) (PEG) which are known to resist protein adsorption and RES clearance. Unfortunately, PEG modification is not without drawbacks including difficulties with the synthesis and associations with immune reactions. To overcome some of these obstacles, we neutralized the NP surface by acetylation and compared this modification to PEGylation for RES clearance and tumor-specific targeting. We found that acetylation was comparable to PEGylation in reducing RES clearance. Additionally, we found that dendrimer acetylation did not impact folic acid (FA)-mediated targeting of tumor cells whereas PEG surface modification reduced the targeting ability of the NP. These results clarify the impact of different NP surface modifications on RES clearance and cell-specific targeting and provide insights into the design of more effective NPs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28705434      PMCID: PMC5653216          DOI: 10.1016/j.bmc.2017.06.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  77 in total

Review 1.  Nanomedicine(s) under the microscope.

Authors:  Ruth Duncan; Rogerio Gaspar
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

2.  PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.

Authors:  Tatsuhiro Ishida; Xinyu Wang; Taro Shimizu; Kosuke Nawata; Hiroshi Kiwada
Journal:  J Control Release       Date:  2007-05-21       Impact factor: 9.776

3.  Polyplex-induced cytosolic nuclease activation leads to differential transgene expression.

Authors:  Rahul Rattan; Sriram Vaidyanathan; Gordon S-H Wu; Anisha Shakya; Bradford G Orr; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2013-07-24       Impact factor: 4.939

Review 4.  Nanoparticle delivery of cancer drugs.

Authors:  Andrew Z Wang; Robert Langer; Omid C Farokhzad
Journal:  Annu Rev Med       Date:  2011-09-01       Impact factor: 13.739

Review 5.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

Review 6.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

7.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

Authors:  Nancy Dos Santos; Christine Allen; Anne-Marie Doppen; Malathi Anantha; Kelly A K Cox; Ryan C Gallagher; Goran Karlsson; Katarina Edwards; Gail Kenner; Lacey Samuels; Murray S Webb; Marcel B Bally
Journal:  Biochim Biophys Acta       Date:  2007-01-03

8.  Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation.

Authors:  Thomas J Styslinger; Ning Zhang; Veer S Bhatt; Nicholas Pettit; Andre F Palmer; Peng G Wang
Journal:  J Am Chem Soc       Date:  2012-04-21       Impact factor: 15.419

9.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.

Authors:  Krishnendu Saha; Mehran Rahimi; Mahdieh Yazdani; Sung Tae Kim; Daniel F Moyano; Singyuk Hou; Ridhha Das; Rubul Mout; Farhad Rezaee; Morteza Mahmoudi; Vincent M Rotello
Journal:  ACS Nano       Date:  2016-04-11       Impact factor: 15.881

10.  Therapeutic siRNA silencing in inflammatory monocytes in mice.

Authors:  Florian Leuschner; Partha Dutta; Rostic Gorbatov; Tatiana I Novobrantseva; Jessica S Donahoe; Gabriel Courties; Kang Mi Lee; James I Kim; James F Markmann; Brett Marinelli; Peter Panizzi; Won Woo Lee; Yoshiko Iwamoto; Stuart Milstein; Hila Epstein-Barash; William Cantley; Jamie Wong; Virna Cortez-Retamozo; Andita Newton; Kevin Love; Peter Libby; Mikael J Pittet; Filip K Swirski; Victor Koteliansky; Robert Langer; Ralph Weissleder; Daniel G Anderson; Matthias Nahrendorf
Journal:  Nat Biotechnol       Date:  2011-10-09       Impact factor: 54.908

View more
  11 in total

1.  Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation.

Authors:  Xiao Hu; Feifei Yang; Yonghong Liao; Lin Li; Guoguang Zhao; Lan Zhang
Journal:  Int J Nanomedicine       Date:  2020-07-28

Review 2.  An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment.

Authors:  Majid Sharifi; William C Cho; Asal Ansariesfahani; Rahil Tarharoudi; Hedyeh Malekisarvar; Soyar Sari; Samir Haj Bloukh; Zehra Edis; Mohamadreza Amin; Jason P Gleghorn; Timo L M Ten Hagen; Mojtaba Falahati
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

3.  Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study.

Authors:  Andrey Kuskov; Dragana Nikitovic; Aikaterini Berdiaki; Mikhail Shtilman; Aristidis Tsatsakis
Journal:  Pharmaceutics       Date:  2022-04-24       Impact factor: 6.525

Review 4.  Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification.

Authors:  Jacob W Shreffler; Jessica E Pullan; Kaitlin M Dailey; Sanku Mallik; Amanda E Brooks
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

Review 5.  The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation.

Authors:  Thai Thanh Hoang Thi; Emily H Pilkington; Dai Hai Nguyen; Jung Seok Lee; Ki Dong Park; Nghia P Truong
Journal:  Polymers (Basel)       Date:  2020-02-02       Impact factor: 4.329

6.  Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer.

Authors:  Hengli Yang; Ping Zhao; Yonggang Zhou; Qiaoying Li; Wenbin Cai; Zongxia Zhao; Jian Shen; Kechun Yao; Yunyou Duan
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

7.  Use of an in silico knowledge discovery approach to determine mechanistic studies of silver nanoparticles-induced toxicity from in vitro to in vivo.

Authors:  Bin-Hsu Mao; Yu-Hsuan Lee; Yi-Kai Luo; Bour-Jr Wang; Chun-Wan Chen; Fong-Yu Cheng; Shian-Jang Yan; Ying-Jan Wang
Journal:  Part Fibre Toxicol       Date:  2022-01-14       Impact factor: 9.400

8.  Nanocarriers targeting adipose macrophages increase glucocorticoid anti-inflammatory potency to ameliorate metabolic dysfunction.

Authors:  Suma Prabhu; Hongping Deng; Tzu-Wen L Cross; Sayyed Hamed Shahoei; Christian J Konopka; Natalia Gonzalez Medina; Catherine C Applegate; Matthew A Wallig; L Wawrzyniec Dobrucki; Erik R Nelson; Andrew M Smith; Kelly S Swanson
Journal:  Biomater Sci       Date:  2020-11-17       Impact factor: 6.843

Review 9.  Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.

Authors:  Zhe Chen; Yuanqiang Zheng; Yanchun Shi; Zhengrong Cui
Journal:  Int J Nanomedicine       Date:  2018-01-09

10.  Pharmacokinetics and biodistribution of a collagen-targeted peptide amphiphile for cardiovascular applications.

Authors:  Hussein A Kassam; Edward M Bahnson; Ana Cartaya; Wulin Jiang; Michael J Avram; Nick D Tsihlis; Samuel I Stupp; Melina R Kibbe
Journal:  Pharmacol Res Perspect       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.